Brivaracetam versus levetiracetam for epilepsy a review of comparative clinical safety

The purpose of this report is to summarize the evidence regarding the comparative clinical safety of BRV compared to LEV among patients with epilepsy with mental health conditions as well as in patients with epilepsy who experienced psychiatric or behavioral adverse events with previous LEV treatmen...

Full description

Bibliographic Details
Main Authors: Subramonian, Anusree, Farrah, Kelly (Author)
Corporate Author: Canadian Agency for Drugs and Technologies in Health
Format: eBook
Language:English
Published: Ottawa Canadian Agency for Drugs and Technologies in Health 2020, December 1, 2020
Edition:Version:1.0
Series:CADTH rapid response report: summary with critical appraisal
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The purpose of this report is to summarize the evidence regarding the comparative clinical safety of BRV compared to LEV among patients with epilepsy with mental health conditions as well as in patients with epilepsy who experienced psychiatric or behavioral adverse events with previous LEV treatment
Physical Description:1 PDF file (35 pages) illustration